ARID2 mutation	Non Small Cell Lung Cancer	ARID2 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
ARID2 mutation	Merkel Cell Carcinoma	ARID2 mutation	Merkel Cell Carcinoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
ARID2 H1495fs*8	Kidney Medullary Carcinoma	ARID2 H1495fs*8	Kidney Medullary Carcinoma	nivolumab Sensitive: C4 – Case Studies nivolumab Sensitive : C4	nivolumab Sensitive: C4 – Case Studies nivolumab Sensitive : C4
H3F3A mutation + ARID2 mutation	Giant Cell Tumor of Bone	H3F3A mutation + ARID2 mutation	Giant Cell Tumor of Bone	denosumab Resistant: C4 – Case Studies denosumab Resistant : C4	denosumab Resistant: C4 – Case Studies denosumab Resistant : C4
EML4-ALK fusion + ARID2-ALK fusion	Lung Adenocarcinoma	EML4-ALK fusion + ARID2-ALK fusion	Lung Adenocarcinoma	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4	crizotinib Sensitive: C4 – Case Studies crizotinib Sensitive : C4

ARID2 (AT-Rich Interaction Domain 2)

Associations(5)